Medicinova, Inc.
Symbol: MNOV (NASDAQ)
0.00
▼ (-100.00%) -1.250
Company Description:
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $1.25
- Yesterday High: $1.29
- Yesterday Low: $1.25
- Yesterday Volume: 20.43K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Medicinova, Inc.
- Website: https://www.medicinova.com
- Listed Date: 2006-12-07
- Location: LA JOLLA, CA
- Market Status: Active
- CIK Number: 0001226616
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $62.29M
- Round Lot: 100
- Outstanding Shares: 49.05M
- Asset Type: CS
RECENT FILINGS FOR MNOV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-22 | S-1 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-01 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-18 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-04-28 | ARS | View |
| 2025-04-28 | DEFA14A | View |
| 2025-04-28 | DEF 14A | View |
| 2025-03-11 | 8-K | View |
| 2025-02-19 | 10-K | View |
| 2025-02-14 | 4 | View |
| 2025-02-14 | 4 | View |
| 2025-02-14 | 4 | View |
| 2025-02-14 | 4 | View |
| 2025-02-14 | 4 | View |
| 2025-01-10 | 4 | View |
| 2025-01-10 | 4 | View |
Latest News on MNOV